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Abstract
Enterohemorrhagic Escherichia coli serotype O157:H7 is a food borne enteric bacterial pathogen that causes significant
morbidity and mortality in both developing and industrialized nations. E. coli O157:H7 infection of host epithelial cells
inhibits the interferon gamma pro-inflammatory signaling pathway, which is important for host defense against microbial
pathogens, through the inhibition of Stat-1 tyrosine phosphorylation. The aim of this study was to determine which
bacterial factors are involved in the inhibition of Stat-1 tyrosine phosphorylation. Human epithelial cells were challenged
with either live bacteria or bacterial-derived culture supernatants, stimulated with interferon-gamma, and epithelial cell
protein extracts were then analyzed by immunoblotting. The results show that Stat-1 tyrosine phosphorylation was
inhibited by E. coli O157:H7 secreted proteins. Using sequential anion exchange and size exclusion chromatography, YodA
was identified, but not confirmed to mediate subversion of the Stat-1 signaling pathway using isogenic mutants. We
conclude that E. coli O157:H7 subverts Stat-1 tyrosine phosphorylation in response to interferon-gamma through a still as
yet unidentified secreted bacterial protein.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC), including the most
common serotype O157:H7, is a non-invasive enteric bacterial
pathogen that causes both sporadic cases and outbreaks of
hemorrhagic colitis and hemolytic-uremic syndrome in humans
[1]. Human zoonotic infections with EHEC occur through the
ingestion of contaminated foodstuffs and water supplies, as well as
from person-to-person transmission of the organism [2].
One of the first lines of host defense against bacterial insults is
through activation of the innate and adaptive immune systems [3].
Pro-inflammatory cytokines, including interferon gamma (IFNc),
are secreted into the extracellular environment and activate an
anti-microbial state in the body [4]. IFNc production by
macrophages, Natural Killer (NK) T cells and activated T cells
triggers an antimicrobial state in host cells by binding to the IFNc
receptor, and tyrosine phosphorylation of the signal transducer
and activator of transcription-1 (Stat-1) molecule. This activation
leads to Stat-1 dimerization and translocation from the cytosol into
the nucleus, where it binds to the gamma activating sequence
(GAS) and triggers the up-regulation of up to 2,000 pro-
inflammatory genes, including inducible nitric oxide synthase
(iNOS), monocyte chemoattractant protein-1 (MCP-1) and
lymphocyte adhesion protein ICAM-1 [5]. An intact IFNc
pathway is essential to combat infection initiated from a wide
range of microbial pathogens; therefore patients with genetic
defects in Stat-1 signaling are susceptible to microbial infections
[6,7,8].
Subversion of the IFNc/Stat-1 signal transduction pathway by
microbial pathogens promotes bacterial colonization and prevents
bacterial clearance from the host [3]. EHEC has evolved a method
to subvert the IFNc pathway, through a still unknown factor [9].
Therefore, the aim of this study was to determine how EHEC
infection disrupts IFNc signal transduction in human epithelial
cells. The findings revealed that the IFNc signal transduction
pathway, important for host defense, is compromised at the level
of Stat-1 tyrosine activation by an unknown EHEC secreted
protein.
Materials and Methods
Tissue culture
HEp-2 epithelial cells (ATCC CCL-23) were used as a model
epithelial cell line, as previously described [10]. Briefly, cells were
grown in minimal essential medium (MEM) containing 15% (v/v)
fetal bovine serum (FBS), 2% (v/v) sodium bicarbonate, 2.5% (v/
v) penicillin streptomycin and 1% (v/v) amphotericin B (all from
Invitrogen, Burlington, Ontario, Canada). Cells were grown in
T75 flasks (Corning Inc., Corning, NY) at 37uCi n5 %C O 2 until
confluent (8610
6 cells/flask). Confluent cells were trypsinized
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Trypsinized cells were then pelleted by centrifugation at 40g for
5 min (Beckman Coulter, Mississauga, ON, Canada), resuspended
in MEM and re-seeded into either 6 well (Becton Dickinson
Labware, NJ) or 24 well dishes (Corning Inc.) and grown at 37uCi n
5% CO2 until confluent. Prior to bacterial infection, cells were
incubated in MEM without antibiotics for 16h at 37uCi n5 %C O 2.
Bacterial strains and growth conditions
Enterohemorrhagic E. coli O157:H7, strain EDL933 (EHEC)
(accession: AE005174.2) and enteropathogenic E. coli O127:H6
strain E2348/69 (EPEC) (accession: NC_011601.1) were used in
this study. Strains were cultured on 5% sheep blood agar plates
(Becton, Dickinson and Company, Sparks, MD) at 37uC for 16h
and stored at 4uC until use. Prior to infecting epithelial cells,
bacteria were grown in 10 ml of static, non-aerated Penassay
broth (Becton, Dickinson Co.) overnight at 37uC.
Bacterial culture supernatants
To collect bacteria culture supernatants, ,1610
9 CFU/ml of
EHEC O157:H7 culture was centrifuged (3,000g, 15 min) and
resuspended in 10 ml of serum free MEM without antibiotics.
After growth for 24h at 37uCi n5 %C O 2, the medium was
centrifuged (3,000g, 15 min), filtered (0.22 mm) and stored at 4uC.
Sterility was confirmed by lack of bacterial growth of 0.1 ml of
culture supernatant plated onto 5% sheep blood agar plates and
then incubated overnight at 37uC.
Proteinase K and heat inactivation treatment of culture
supernatants
Bacterial culture supernatants from EHEC were incubated with
proteinase K conjugated to agarose beads (10 to 1000 mg/ml, 1h
shaking, 37uC) (Sigma Aldrich, Oakville, Ontario, Canada).
Culture supernatants incubated with agarose beads and pre-
incubated with bovine serum albumin (5% BSA) were used as a
negative control. After incubation, agarose beads were removed
from the solution by centrifugation (3,000g, 1 min) before
incubation with HEp-2 cells. Culture supernatants from EHEC
were also heat inactivated by boiling (100uC, 0.5h) and cooled to
37uC before incubation with HEp-2 cells.
Epithelial cell infection
Infection of HEp-2 cells was performed at a multiplicity of
infection (MOI) of 100:1. Overnight bacterial culture (10mL) was
centrifuged (3,000g, 10 min), the supernatant decanted, and
bacterial pellets resuspended in 1.0 ml of antibiotic and serum-
free MEM. An aliquot of this bacterial suspension (,1610
8 CFU
in 0.1 ml) was then used to infect confluent HEp-2 monolayers
grown in 6 well plates (,1610
6 cells/well). The cells were infected
with either EHEC or EPEC for 6h at 37uCi n5 %C O 2. Cells were
then washed with PBS and stimulated with IFNc (50 ng/ml; 0.5h
at 37uCi n5 %C O 2), followed by whole cell protein extracts for
immunoblotting. To determine if active bacterial protein synthesis
was required to inhibit the phosphorylation of Stat-1, in a subset of
experiments epithelial cells and EHEC were incubated with
chloramphenicol (100 mg/ml) at 0 to 4h after infectious challenge
with (MOI 100:1, 6h).
Immunoblotting
Whole cell protein extracts were collected by resuspending
epithelial cells in RIPA buffer (1% Nonidet P-40, 0.5% sodium
deoxylate, 0.1% sodium dodecyl sulfate [SDS] in PBS) supplement-
ed with 150 mM NaCl, 50 mM sodium fluoride, 1 mM sodium
orthovanadate, 20 mg/ml phenylmethylsulfonyl fluoride, 15 mg/ml
aprotinin, 2 mg/ml leupeptin, and 2 mg/ml pepstatin A (all from
Sigma Aldrich). Aliquots were applied directly onto cells, mixed and
leftonicefor0.5h.Re-suspendedpelletswerecentrifugedat20,000g
for 1 min at 4uC. Supernatants were collected and stored at 280uC
until further analysis by western blotting.
Immunoblotting was conducted by combining whole cell protein
extracts with SDS-PAGE loading buffer in a 1:1 (v/v) ratio,
incubationat100uCfor3 min,followedbyloadingintoprecast10%
polyacrylamide gels (Ready GelH; BioRad Laboratories, Hercules,
CA). Gels were electrophoresed (150 V, 1h at room temperature),
followed by protein transfer onto nitrocellulose membranes
(BioTrace NT; Pall Corporation, Ann Arbor, MI) (110 V, 1h at
4uC). Membranes were incubated in Odyssey blocking buffer
(Mandel Scientific Company Inc., Guelph, Ontario, Canada) for
0.5h at room temperature on a shaker, followed by incubation with
primary antibodies (4uC overnight on a shaker). Primary antibodies
included rabbit anti-native-Stat-1 (1 in 1,000 dilution; Cell
Signaling, Beverly, MA), rabbit anti-phospho-Stat-1 (1 in 1,000
dilution; Cell Signaling), rabbit anti-IRF1 (1 in 2,000 dilution;
Sigma-Aldrich), and mouse anti-b-actin (1 in 5,000 dilution; Sigma).
Membraneswerewashed3timeswithPBS+0.1%Tween(5 minper
wash) and then incubated with secondary antibodies (1h at RT on a
shaker). Secondary antibodies included IRDye 800 goat anti-rabbit
IgG (1 in 20,000 dilution; Rockland Immunochemicals, Gilberts-
ville, PA) and Alexa FluorH 680 goat anti-mouse IgG (1 in 20,000
dilution; Molecular Probes, Eugene, OR).
Immunoblots were scanned into an infrared imaging system
(Odyssey, LI-COR Biosciences, Lincoln, NE), using both the
700 nm and 800 nm channels, at a resolution of 169 mm. Using
automated software (LI-COR Biosciences) densitometry was
performed to obtain the integrative intensity of positively stained
bands. Integrative intensity values for each of the phospho-Stat-1
and native-Stat-1 bands were normalized to the integrative
intensity values obtained for the corresponding b-actin bands.
Uninfected cells stimulated with IFNc were used as positive
controls, and standardized to 100%. Densitometry values obtained
from samples incubated with live bacteria, or sterile culture
supernatants, were then calculated as a percentage of the positive
uninfected control.
Column chromatography. Bacterial culture supernatants
were diluted 1 in 3 with 10 mM Tris-HCL buffer (pH 8.0) and
applied onto a DEAE Sephacel anion exchange column (Sigma
Aldrich, Oakville, Ontario, Canada), and proteins eluted with
increasing concentrations of sodium chloride (0 to 1 M). Protein
fractions were dialyzed in 10 mM Tris-HCL buffer (pH 8.0)
overnight at 4uC, and further separated using a size exclusion
column containing Sepharose CL-6B (Sigma-Aldrich). Fractions
were screened for activity in inhibiting IFNc mediated Stat-1-
phosphorylation. Active fractions were analyzed by 18% SDS-
PAGE followed by silver staining. Candidate proteins were excised
and identified using Mass Spectrometry (Advanced Protein
Technology Centre at The Hospital for Sick Children, Toronto,
Ontario, Canada).
Isogenic mutant strains
Isogenic etpD (1.9Kb), yodA (672bp), and escN (1.3Kb) mutants
were generated from EHEC O157:H7 strain EDL933 using a one-
step inactivation technique and primers detailed in Table 1 [11].
Briefly, EDL933 was transformed with pKD46, and l-red
recombinase expression induced with L-arabinose at 30uCo na
shaker until the OD600 reached 0.6. etpD mutants were generated
by electroporating linear DNA fragments containing a kanamycin
resistance cassette with 59 and 39 flanking regions homologous to
E. coli O157:H7 Inhibits Stat-1 Phosphorylation
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(template plasmid with FLP recognition target sites flanking a
1.6Kb kanamycin resistance gene). yodA mutants were generated in
the same fashion, except with primers yodAKOP1 and yodA-
KOP2, and escN mutants with primers escNKOP1 and escN-
KOP2. All mutants generated were verified by PCR.
EHEC pO157 plasmid removal
The pO157 plasmid was cured from EHEC using the pCURE2
kit from Plasgene (Plasgene, Birmingham UK) [12]. Briefly,
Escherichia coli O157:H7 strain EDL933 was transformed with the
pCURE2 plasmid which displaces the pO157 plasmid, and
transformants were selected for resistance on LB kanamycin plates
(50 mg/ml). Transformants were then counter-selected for sucrose
sensitivity (sacB) by incubation on LB plates supplemented with 5%
sucrose, and colonies recovered were verified for their loss of the
pO157 and pCURE2 plasmids by PCR.
YodA cloning, over-expression and purification
To over-express and purify the YodA protein (24.6kDa), the
yodA gene was cloned into the pBAD-TOPO TA cloning kit
(Invitrogen) under control of the arabinose promoter. Briefly, the
yodA gene was PCR amplified using primers yodA-C’P1 and yodA-
C’P2, cloned upstream of a 6x-His tag to generate pBAD-yodA-
His, and verified using PCR and DNA sequencing (Centre for
Applied Genomics, Hospital for Sick Children, Toronto, Ontario,
Canada). YodA over-expression was induced in Escherichia coli
DH5a with 0.2% arabinose and purified using nickel column
chromatography employing a Qiagen His-tagged purification kit
(Qiagen, Toronto).
Statistics
Results are expressed as means, 6 standard error (SE). Levels of
Stat-1 tyrosine phosphorylation were compared by using one-way
analysis of variance (ANOVA), with Tukey’s multiple comparison
test. Analyses were performed using Prism4 (GraphPad, San Diego,
California,USA).Differencesofp,0.05wereconsideredsignificant.
Results
EHEC, but not EPEC, inhibits IFNc mediated Stat-1
tyrosine phosphorylation via secreted factors
To demonstrate that EHEC, but not EPEC, was able to subvert
the IFNc pathway, we assessed the tyrosine phosphorylation state
Table 1. Primers employed in this study.
Name Sequence (59-.39)
etpDKOP1 GTGTTCACTACAGTAATTTTGGGGGCCATTCCAGGGTGGGGGGCTGAATTGTGTAGGCTGGAGCTGCTTC
etpDKOP2 TTACATCTCCTGCGCATAAAACGCAGCAATCGCCGCTTTCACCTTCCGGACATATGAATATCCTCCTTAG
escNKOP1 ATGATTTCAGAGCATGATTCTGTATTGGAAAAATACCCACGTGTAGGCTGGAGCTGCTTC
escNKOP2 GGCAACCACTTTGAATAGGCTTTCAATCGTTTTTTCGTAACATATGAATATCCTCCTTAG
YodAKOP1 TTGGCGATTCGTCTTCACAAACTGGCTGTTGCTTTAGGTGTCTTTATTGTGTGTAGGCTGGAGCTGCTTC
YodAKOP2 TCAATGAGACATCATTTCCTCGACCACTTCTTCGCTACTCAACTGATATGCATATGAATATCCTCCTTAG
yodA-C’P1 GAGGAATAATAAATGACTCTGGAGGAAACTGTTTTGG
yodA-C’P2 ATGAGACATCATTTCCTCGACCAC
doi:10.1371/journal.pone.0030145.t001
Figure 1. EHEC, but not EPEC, inhibits IFNc mediated Stat-1 tyrosine phosphorylation. Whole-cell protein extracts from HEp-2 cells
analyzed by immunoblotting showed that (A) IFNc mediated (50ng/ml, 0.5h) Stat-1 tyrosine phosphorylation is suppressed by enterohemorrhagic
Escherichia coli O157:H7, strain EDL933 (EHEC), but not by enteropathogenic Escherichia coli O127:H6, strain E2348/69 (EPEC) (MOI of 100:1; 6h). (B)
Incubation with sterile culture supernatants (6h) from EHEC, but not EPEC, suppressed IFNc-mediated tyrosine phosphorylation of Stat-1. (C)
Incubation with chloramphenicol (100 mg/ml) up to 1h after infection with EHEC (MOI 100:1; 6h) prevented EHEC suppression of IFNc mediated Stat-1
tyrosine phosphorylation.
doi:10.1371/journal.pone.0030145.g001
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is normally not tyrosine phosphorylated, but becomes activated in
response to IFNc stimulation [5,9]. Infection with either pathogen
does not affect native Stat-1 expression (Figure 1A), however
EHEC prevented Stat-1 tyrosine phosphorylation in response to
IFNc stimulation (Figure 1A). By contrast, EPEC did not inhibit
IFNc mediated Stat-1 tyrosine phosphorylation [9,13-Submitted],
indicating that the ability to subvert IFNc signaling is a specific
ability of EHEC, and not all pathogenic E. coli.
Incubation of HEp-2 cells with sterile culture supernatants
showed that EHEC, but not EPEC, culture supernatants are able
to inhibit IFNc mediated Stat-1 tyrosine phosphorylation, with no
Figure 2. Secreted factor(s) have protein qualities. Whole cell protein extracts from HEp-2 cells analyzed by immunoblotting showed that (A)
Incubation with heat treated (100uC, 0.5h) EHEC CS did not suppress IFNc mediated Stat-1 tyrosine phosphorylation, and (B) incubation with EHEC CS
(6h) pre-treated with proteinase K conjugated to agarose beads (0 – 1,000mg/ml, 37uC, 1h) did not suppress IFNc induced tyrosine phosphorylation
of Stat-1 (n=3, one-way ANOVA, * p,0.05).
doi:10.1371/journal.pone.0030145.g002
Figure 3. EHEC secreted inhibitory factor identified as YodA. A Bradford assay was performed on EHEC culture supernatants separated by
anion exchange (A). A 1.2cm by 50cm column containing DEAE Sephacel that had been mixed with 0.5L of culture supernatant was initially rinsed
with low salt buffer prior to being eluted with a 0 to 1M gradient of NaCl. Three mL fractions were collected and protein content was determined by
Bradford assay. Fraction 60 represents a NaCl concentration of ,200mM and no further protein elution at higher salt concentrations was observed.
Fractions of interest were pooled and dialyzed before incubation with HEp-2 cells, and tested for their ability to inhibit IFNc mediated Stat-1 tyrosine
phosphorylation (B). Pooled fractions 32–43 from the DEAE Sephacel column were concentrated by membrane filtration prior to being subjected to
size exclusion chromatography using a 1.2cm by 50cm Sepharose CL-6B column equilibrated with 10 mM Tris-HCL buffer (pH 8.0). Three mL fractions
were collected and the protein concentration present was determined by Bradford assay (C). Select fractions from size exclusion chromatography
were tested for their ability to inhibit IFNc mediated Stat-1 tyrosine phosphorylation (D). Fractions of interest were separated using 18% SDS-PAGE
and stained with silver (E).
doi:10.1371/journal.pone.0030145.g003
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additionofchloramphenicolwithin1h ofEHECinfectionprevented
bacterial inhibition of Stat-1 tyrosine phosphorylation in response to
IFNc (Figure 1C), suggesting that subversion of IFNc mediated
Stat-1 tyrosine phosphorylation is time dependent, and requires new
and active bacterial protein synthesis [13-Submitted].
Secreted inhibitory factor(s) have protein-like qualities
To verify that the inhibitory effects of EHEC were not due to
heat resistant factors, such as lipopolysaccharide [14,15], culture
supernatants were incubated at 100uC for 30 min and then
assessed for the ability to inhibit Stat-1 tyrosine phosphorylation.
As observed previously in our laboratory [13-Submitted], boiled
culture supernatants did not inhibit Stat-1 tyrosine phosphoryla-
tion, even after 6h of incubation with tissue culture epithelial cells
(Figure 2A).
To confirm that the inhibitory factor(s) were protein in nature,
bacterial culture supernatants were treated with proteinase K, and
then tested for their ability to inhibit Stat-1 tyrosine phosphory-
lation. Culture supernatants treated with agarose beads as a
negative control still blocked signaling responses to IFNc, while
those treated with increasing concentrations of proteinase K
progressively lost the ability to subvert IFNc mediated Stat-1
tyrosine phosphorylation (Figure 2B) [13-Submitted].
EHEC secreted inhibitory factor identified as YodA
In order to identify the secreted inhibitory factor(s), we
separated the protein contents of EHEC culture supernatants
based on charge density differences using anion exchange
chromatography. After an initial loading and low salt rinsing step,
bound material was eluted using a linear salt gradient, and
fractions were collected at regular intervals and analyzed for their
protein concentration using the Bradford assay (Figure 3A).
Fractions from distinct regions of the anion exchange profile were
pooled into 4 groups, dialyzed, and incubated with HEp-2 cells.
Only fractions 32–43 inhibited IFNc mediated Stat-1 tyrosine
phosphorylation (Figure 3B). In order to further identify the
inhibitory factor(s), fractions 32-43 from the DEAE column were
pooled and separated using size exclusion chromatography to
separate the proteins based on molecular mass. Fractions from the
size exclusion column were then retested for protein concentration
using the Bradford assay (Figure 3C), and tested for their ability
to inhibit IFNc mediated Stat-1 tyrosine phosphorylation
(Figure 3D). According to western blotting, fractions 13–16
showed inhibitory qualities, which appeared to correspond to the
presence of a single band present in fractions 14–16 when
separated by SDS-PAGE (Figure 3E). The band was excised,
digested by trypsin, and identified as YodA by standard methods
of peptide fingerprint analysis using mass spectrometry (Advanced
Protein Technology Centre at The Hospital for Sick Children,
Toronto, Ontario, Canada). YodA is a metal binding protein of
unknown function [16,17]. To determine if YodA played a role in
Stat-1 suppression, isogenic yodA mutants in E. coli O157:H7 strain
EDL933 were created using the l-red knockout system [11] along
with the E. coli Type-2 Secretion system (etpD) which is required for
YodA excretion [18]. Both isogenic mutants were verified by PCR
(Figure 4A, B), and then assessed for their ability to inhibit Stat-
1-phosphorylation (Figure 4C, D).
Contrary to expectations, both isogenic mutants inhibited Stat-1-
phosphorylationat levels comparable to the wild-type EHEC strain,
indicating that neither yodA nor etpD was involved in EHEC
subversion of IFNc/Stat-1 signaling. To verify the mutation
Figure 4. Isogenic yodA and etpD mutants inhibit Stat-1 tyrosine phosphorylation at levels comparable tos wild-type. Isogenic yodA
and etpD mutants were verified by PCR (panels A and B, respectively). Whole-cell protein extracts from HEp-2 cells were incubated with sterile culture
supernatants from WT, yodA and etpD mutants and then tested for their ability to inhibit IFNc mediated Stat-1 tyrosine phosphorylation;
representative immunoblot (C) and repeated experiments analyzed by densitometry (n=3) (D).
doi:10.1371/journal.pone.0030145.g004
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protein expression system with a C-terminal histidine tag
(Figure 5A), and verified by PCR (Figure 5B) and sequencing.
Protein over-expression and solubility was verified using western
blotting (Figure 5C) and then purified by nickel column
chromatography (Figure5D). Varying concentrations of the eluted
and dialyzed YodA-His protein (Figure 5E, F, respectively) were
then tested directly on HEp-2 cells; however, purified YodA did not
inhibit IFNc mediated Stat-1 tyrosine phosphorylation.
Discussion
In the present study, we have shown that EHEC, but not EPEC,
subverts the IFNc signaling pathway at the level of Stat-1 tyrosine
phosphorylation. Direct contact of the non-invasive enteric
pathogen with host cells is not required to mediate this effect, as
extracellular bacterial culture medium was able to produce the
effect associated with the subversion factor in the absence of intact
bacteria. Through a series of biochemical tests, we establish in this
report that the secreted bacterial factor has properties consistent
with it being a protein (Figure 2), but it is not secreted via the type
two secretion protein export system.
Recent studies have found that subversion of innate immune
pathways is a theme common to multiple pathogens, illustrating
the important role of the IFNc signal transduction pathway in
combating microbial infections [3]. For example, viruses of the
Paramyxoviridae family subvert the IFNc pathway by degrading
intracellular Stat-1 [19], while the parasite Leishmania donovani
Figure 5. Purified YodA failed to inhibit Stat-1 tyrosine phosphorylation as well as wild-type culture supernatant. EHEC yodA gene
was cloned into the pBAD protein expression vector (A) and verified by PCR (B). Over-expressed YodA-His was detected in the soluble fraction, but
not in the insoluble or supernatant fraction, by western blot (C) and purified using nickel column chromatography (D). Varying concentrations of
eluted and dialyzed YodA-His were tested for the ability to inhibit IFNc mediated Stat-1 tyrosine phosphorylation (panels E and F, respectively).
doi:10.1371/journal.pone.0030145.g005
Figure 6. EHEC LEE and pO157 are not involved in the suppression of the IFNc signaling pathway. Isogenic escN, and pO157 cured
mutants were tested for their ability to inhibit IFNc mediated Stat-1 tyrosine phosphorylation (A and B, respectively).
doi:10.1371/journal.pone.0030145.g006
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EHEC O157:H7 to suppress the IFNc pathway could promote its
ability to colonize the gut of the infected host by reducing immune
surveillance [3].
EHEC and EPEC both contain an array of virulence factors
that aid in infection, of which the LEE (Locus of Enterocyte
Effacement) pathogenicity island encoded type three secretion
system (T3SS) is common to both; allowing the bacterium to
adhere intimately onto host cells. The LEE’s of EHEC and EPEC
were acquired through horizontal gene transfer and provide these
non-invasive pathogens the ability to deliver effector proteins
directly into host cells [21]. These effectors allow the bacterium to
subvert host cytoskeleton processes, destroy brush border micro-
villi, and cause rearrangements of F-actin resulting in attaching
and effacing (A/E) lesions on epithelial cell surfaces [22,23,24].
Studies on the T3SS and its protein effectors have shown that
many of these bacterial-derived proteins have redundant and
overlapping functions, each of which appears to have multiple
roles in subverting eukaryotic cellular processes, and thereby aid in
disease pathogenesis [25]. Despite both pathogens having a LEE,
they are not identical, and many of the effectors, while having
similar effects on host cells, can vary between the two enteric
pathogens [26,27]. However, the EHEC LEE is not involved in
subverting the IFNc signaling pathway, as demonstrated in this
report by showing that an isogenic escN mutant suppresses Stat-1
tyrosine phosphorylation comparable to the parental wild-type
strain (Figure 6A).
EHEC also contains other virulence factors distinct from EPEC,
which gives this enteric pathogen the ability to inhibit Stat-1
tyrosine phosphorylation. For instance, EHEC contains phage
encoded Shiga toxins, which are responsible for causing
hemorrhagic colitis and hemolytic-uremic syndrome [28,29].
EHEC also harbors the pO157 virulence plasmid that encodes a
metalloprotease (stcE) [30], a serine protease (espP) [31], a
hemolysin (ehxA) [32], a catalase-peroxidase (katP) [33], a putative
adhesion (toxB) [34], as well as 22 other open reading frames that
have no strong similarity with any known proteins [35]. However,
the EHEC pO157 plasmid is also not involved in subverting the
IFNc signal transduction pathway, because a pO157 plasmid
cured mutant suppressed Stat-1 tyrosine phosphorylation compa-
rable to the parental wild-type strain (Figure 6B).
The expression of the YodA protein in bacterial supernatants
leads to its co-purification with the Stat-1-P inhibitory activity that
was present in the sample. Further, the relatively small size of the
protein, ,25kD, was consistent with the observed behavior of the
inhibitory activity when supernatant was passed through filters
with defined molecular cut–offs. YodA therefore appeared to
match the characteristics of the inhibitor molecule, however our
inability to detect Stat-1-P suppression in the presence of overly
expressed YodA (Figure 5C–D) suggests that this protein is either
not the inhibitor, or alternatively it is dysfunctional in the form in
which it is expressed. It’s recovery as a small molecule on the size
exclusion column suggests that it does not natively pair with
another protein or entity for activity, however the resolution of the
DEAE and the Sepharose CL-6B columns may not be sufficient to
detect if specific post-translational modifications are required to
create the activate form of the YodA protein. Nonetheless, the
inability of the purified YodA protein to suppress Stat-1 tyrosine
phosphorylation, in addition to the yodA mutant’s preserved ability
to suppress Stat-1 tyrosine phosphorylation, indicates that EHEC
likely utilizes a different protein factor to suppress IFNc activation.
EHEC undoubtedly contains other virulence factors which are
distinct from EPEC, but which are currently uncharacterized.
Recent studies have shown that EHEC, strain EDL933 (5.62Mb;
5,312 genes) is roughly 11% larger than EPEC strain E2348/69
(5.07Mb; 4,554 genes) [36]. Further research focusing on the
differences between the EHEC and EPEC genomes will elucidate
the EHEC-derived protein factor that is responsible for the
subversion of the IFNc signaling pathway. Identification of this
inhibitory factor(s) could potentially be used to restore host cell
signaling responses following EHEC infection and, thereby,
reduce the severity and spread of this infectious agent.
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